Tomohiro Kikuta
Papers
1
Total Citations
41
H-Index
1
About
Tomohiro Kikuta is a prominent researcher whose work bridges immunology and renal pathophysiology, with a particular focus on the renin-angiotensin system (RAS) in inflammatory kidney diseases. His key contributions center on understanding how angiotensin II receptors modulate immune-mediated glomerulonephritis, a critical area for developing targeted therapies. In his most-cited study (41 citations), Kikuta demonstrated a possible anti-inflammatory role for the angiotensin II type 2 receptor (AT2R) during type 1 receptor (AT1R) blockade in immune-mediated glomerulonephritis. This work provided foundational insights into how RAS blockade can shift inflammatory responses, offering a dual-receptor perspective that has influenced subsequent research on kidney inflammation and therapeutic strategies. Though his citation count reflects a focused, early-career impact, Kikuta’s findings have been instrumental in advancing the understanding of receptor-specific signaling in renal immunology. His research is particularly notable for its translational potential, highlighting how manipulating AT2R activity could mitigate inflammation when AT1R is suppressed—a concept with implications for treating autoimmune and hypertensive kidney diseases. For students and researchers, Kikuta’s work exemplifies how targeted receptor studies can unravel complex disease mechanisms and inspire novel therapeutic avenues.
Research Focus
Key Achievements
Top Papers
- 1